“Plate Cherry Picking”: A Novel Semi-Sequential Screening Paradigm for Cheaper,Faster,Information-Rich Compound Selection

Abstract

This work describes a novel semi-sequential technique for in silico enhancement of high-throughput screening (HTS) experiments now employed at Novartis. It is used in situations in which the size of the screen is limited by the readout (e.g., high-content screens) or the amount of reagents or tools (proteins or cells) available. By performing computational chemical diversity selection on a per plate basis (instead of a per compound basis), 25% of the 1,000,000-compound screening was optimized for general initial HTS. Statistical models are then generated from target-specific primary results (percentage inhibition data) to drive the cherry picking and testing from the entire collection. Using retrospective analysis of 11 HTS campaigns, the authors show that this method would have captured on average two thirds of the active compounds (IC₅₀ < 10 µM) and three fourths of the active Murcko scaffolds while decreasing screening expenditure by nearly 75%. This result is true for a wide variety of targets, including G-protein-coupled receptors, chemokine receptors, kinases, metalloproteinases, pathway screens, and protein-protein interactions. Unlike time-consuming “classic” sequential approaches that require multiple iterations of cherry picking, testing, and building statistical models, here individual compounds are cherry picked just once, based directly on primary screening data. Strikingly, the authors demonstrate that models built from primary data are as robust as models built from IC₅₀ data. This is true for all HTS campaigns analyzed, which represent a wide variety of target classes and assay types. (Journal of Biomolecular Screening 2007:320-327)

Keywords

cherry picking high-throughput screening semi-sequential screening plate diversity approach

References

Hann MM , Oprea TI : Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 2004;8:255-263.

Sneader W. : Drug Prototypes and their Exploitation. London: John Wiley, 1996.

Macarron R. : Critical review of the role of HTS in drug discovery. Drug Discov Today 2006;11:277-279.

Davies JW , Glick M. , Jenkins JL : Streamlining lead discovery by aligning in silico and high-throughput screening . Curr Opin Chem Biol 2006;10:1-9.

Schnecke V. , Bostrom J. : Computational chemistry-driven decision making in lead generation. Drug Discov Today 2006;11:43-50.

Shoichet BK : Virtual screening of chemical libraries. Nature 2004; 432:862-865.

Chin DN , Chuaqui CE , Singh J. : Integration of virtual screening into the drug discovery process. Mini Rev Med Chem 2004;4:1053-1065.

Young SS , Lam RL , Welch WJ : Initial compound selection for sequential screening. Curr Opin Drug Discov Dev 2002;5:422-427.

Bender A. , Glen RC : Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2004;2:3204—3218.

10.

Bender A. , Jenkins JL , Li Q. , Adams SE , Cannon EO , Glen RC : Molecular similarity: advances in methods, applications and validations in virtual screening and QSAR. Annu Rep Comput Chem 2006;2:145—173.

11.

Jenkins JL , Glick M. , Davies JW : A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. J Med Chem 2004;47:6144—6159.

12.

Hert J. , Willett P. , Wilton DJ , Acklin P. , Azzaoui K. , Jacoby E. , et al: New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searching . J Chem Inf Model 2006;46:462-470.

13.

Hert J. , Willett P. , Wilton DJ , Acklin P. , Azzaoui K. , Jacoby E. , et al: Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. Org Biomol Chem 2004; 2:3256-3266.

14.

Rusinko A. , Farmen MW , Lambert CG , Brown PL , Young SS : Analysis of a large structure/biological activity data set using recursive partitioning. J Chem Inf Comput Sci 1999;39:1017-1026.

15.

Glick M. , Klon AE , Acklin P. , Davies JW : Enrichment of extremely noisy high-throughput screening data using a naive Bayes classifier. J Biomol Screen 2004;9:32-36.

16.

Diller DJ , Hobbs DW : Deriving knowledge through data mining high-throughput screening data. J Med Chem 2004;47:6373-6383.

17.

Warmuth MK , Liao J. , Ratsch G. , Mathieson M. , Putta S. , Lemmen C. : Active learning with support vector machines in the drug discovery process. J Chem Inf Comput Sci 2003;43:667-673.

18.

Makino S. , Kuntz ID : Automated flexible ligand docking method and its application for database search. J Comput Chem 1997;18:1812-1825.

19.

Rarey M. , Kramer B. , Lengauer T. , Klebe G. : A fast flexible docking method using an incremental construction algorithm . J Mol Biol 1996; 261:470-489.

20.

Jones G. , Willett P. , Glen RC , Leach AR , Taylor R. : Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727-748.

21.

Friesner RA , Banks JL , Murphy RB , Halgren TA , Klicic JJ , Mainz DT , et al: Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739-1749.

22.

Abagyan R. , Totrov M. , Kuznetsov D. : ICM—a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J Comput Chem 1994;15:488-506.

23.

Valler MJ , Green D. : Diversity screening versus focused screening in drug discovery. Drug Discov Today 2000;5:286-293.

24.

Bemis GW , Murcko MA : The properties of known drugs. 1. Molecular frameworks. J Med Chem 1996;39:2887-2893.

25.

Xia X. , Maliski EG , Gallant P. , Rogers D. : Classification of kinase inhibitors using a Bayesian model. J Med Chem 2004;47:4463-4470.

26.

Bishop AC , Ubersax JA , Petsch DT , Matheos DP , Gray NS , Blethrow J. , et al: A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 2000;407:395-401.

27.

Gray NS , Wodicka L. , Thunnissen AM , Norman TC , Kwon S. , Espinoza FH , et al: Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 1998 ;281:533-538.

28.

Johnson SA , Hunter T. : Kinomics: methods for deciphering the kinome. Nat Methods 2005;2:17-25.

29.

Nidhi, Glick M , Davies JW , Jenkins JL : Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases . J Chem Inf Model 2006;46:1124-1133.

30.

Roche O. , Schneider P. , Zuegge J. , Guba W. , Kansy M. , Alanine A. , et al: Development of a virtual screening method for identification of “frequent hitters ” in compound libraries. J Med Chem 2002;45:137-142.

31.

Seidler J. , McGovern S. , Doman T. , Schoichet B. : Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 2003;46:4477-4486.

32.

McGovern S. , Caselli E. , Grigorieff N. , Schoichet B. : A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45:1712-1722.

33.

McGovern SL , Shoichet BK : Kinase inhibitors: not just for kinases anymore . J Med Chem 2003;46:1478-1483.